Back
 Health  Vol.8 No.9 , June 2016
Critical Evaluation for Alternative Causes of Drug Induced and Herbal Induced (DILI/HILI) Hepatotoxicity
Abstract: The objective of this review is to highlight the continued exclusion of discussion in the literature regarding alternative causes and proper causality assessment of cases of hepatotoxicity when use of dietary supplements is reported. Though independent experts are working diligently to advance the discussion related to alternative causes of hepatotoxicity resulting in idiosyncratic drug-induced liver injury/herb-induced liver injury (DILI/HILI), the literature continues to recite the same cases, such as those presented here, to reiterate potentially biased positions and ignore current, standardized and valid evaluations utilizing the Roussel Uclaf Causality Assessment Method (RUCAM). Several historical cases purporting hepatotoxicity induced by use of dietary supplements are presented in this review to demonstrate how such cases may be improperly assessed due to bias, inconsistent use of causality assessment methods, as well as use of causality assessment methods deemed obsolete. This in essence, delays any true progress in establishing sound criteria to determine and address the actual cause(s) of DILI/HILI.
Cite this paper: Frankos, V. , Najeeullah, R. and Morgan, J. (2016) Critical Evaluation for Alternative Causes of Drug Induced and Herbal Induced (DILI/HILI) Hepatotoxicity. Health, 8, 800-804. doi: 10.4236/health.2016.89084.
References

[1]   Teschke, R., Wolff, A., Frenzel, C., Schulze, J. and Eickhoff, A. (2012) Herbal Hepatotoxicity: A Tabular Compilation of Reported Cases. Liver International, 32, 1543-1556.
http://dx.doi.org/10.1111/j.1478-3231.2012.02864.x

[2]   Teschke, R., Frenzel, C., Schulze, J., Schwarzenboeck, A. and Eickhoff, A. (2013) Herbalife Hepatotoxicity: Evaluation of Cases with Positive Reexposure Tests. World Journal of Hepatology, 5, 353-363.
http://dx.doi.org/10.4254/wjh.v5.i7.353

[3]   Teschke, R., Schulze, J., Schwarzenboeck, A., Eickhoff, A. and Frenzel, C. (2013) Herbal Hepatotoxicity: Suspected Cases Assessed for Alternative Causes. European Journal of Gastroenterology & Hepatology, 25, 1093-1098.
http://dx.doi.org/10.1097/MEG.0b013e3283603e89

[4]   Zambrone, F.A., Corrêa, C.L. and Amaral, L.M. (2015) A Critical Analysis of the Hepatotoxicity Cases Described in the Literature Related to Herbalife? Products. Brazilian Journal of Pharmaceutical Sciences, 51, 785-796.
http://dx.doi.org/10.1590/S1984-82502015000400004

[5]   Anderson, J.W. and Konz, E.C. (2001) Obesity and Disease Management: Effects of Weight Loss on Comorbid Conditions. Obesity Research, 9, 326S-334S.
http://dx.doi.org/10.1038/oby.2001.138

[6]   Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., Charlton, M. and Sanyal, A.J. (2012) The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 55, 2005-2023.
http://dx.doi.org/10.1002/hep.25762

[7]   Promrat, K., Kleiner, D.E., Niemeier, H.M., Jackvony, E., Kearns, M., Wands, J.R., Fava, J.L. and Wing, R.R. (2001) Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis. Hepatology, 51, 121- 129.
http://dx.doi.org/10.1002/hep.23276

[8]   Schaffer, J.E. (2003) Lipotoxicity: When Tissues Overeat. Current Opinion in Lipidology, 14, 281-287.
http://dx.doi.org/10.1097/00041433-200306000-00008

[9]   Brookheart, R.T., Michel, C.I. and Schaffer, J.E. (2009) As a Matter of Fat. Cell Metabolism, 10, 9-12.
http://dx.doi.org/10.1016/j.cmet.2009.03.011

[10]   Neuschwander-Tetri, B.A. (2010) Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: The Central Role of Nontriglyceride Fatty Acid Metabolites. Hepatology, 52, 774-788.
http://dx.doi.org/10.1002/hep.23719

[11]   Caprai, S., Vajro, P., Ventura, A., Sciveres, M. and Maggiore, G. (2008) SIGENP Study Group for Autoimmune Liver Disorders in Celiac Disease. Autoimmune Liver Disease Associated with Celiac Disease in Childhood: A Multicenter Study. Clinical Gastroenterology and Hepatology, 6, 803-806.
http://dx.doi.org/10.1016/j.cgh.2007.12.002

[12]   Villalta, D., Girolami, D., Bidoli, E., Bizzaro, N., Tampoia, M., Liguori, M., Pradella, M., Tonutti, E. and Tozzoli, R. (2005) High Prevalence of Celiac Disease in Autoimmune Hepatitis Detected by Anti-Tissue Tranglutaminase Autoantibodies. Journal of Clinical Laboratory Analysis, 19, 6-10.
http://dx.doi.org/10.1002/jcla.20047

[13]   Volta, U. (2009) Pathogenesis and Clinical Significance of Liver Injury in Celiac Disease. Clinical Reviews in Allergy & Immunology, 36, 62-70.
http://dx.doi.org/10.1007/s12016-008-8086-x

[14]   Guturu, P. and Duchini, A. (2012) Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity, Insulin Resistance and Mechanisms of Hepatotoxicity. International Journal of Hepatology, 2012, 8 p.

[15]   Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M. and Marchesini, G. (2005) Endothelial Dysfunction and Cardiovascular Risk Profile in Nonalcoholic Fatty Liver Disease. Hepatology, 42, 473-480.
http://dx.doi.org/10.1002/hep.20781

[16]   Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G. and Leo, E. (2007) A Prospective Study of Acute Drug-Induced Liver Injury in Patients Suffering from Non-Alcoholic Fatty Liver Disease. Hepatology Research, 37, 410-415.
http://dx.doi.org/10.1111/j.1872-034X.2007.00072.x

[17]   Dalton, H.R., Fellows, H.J., Stableforth, W., Joseph, M., Thurairajah, P.H., Warshow, U., Hazeldine, S., Remnarace, R., Ijaz, S., Hussaini, S.H. and Bendall, R.P. (2007) The Role of Hepatitis E Virus Testing in Drug-Induced Liver Injury. Alimentary Pharmacology & Therapeutics, 26, 1429-1435.
http://dx.doi.org/10.1111/j.1365-2036.2007.03504.x

[18]   Davern, T.J., Chalasani, N., Fontana, R.J., Hayashi, P.H., Protiva, P., Kleiner, D.E., Engle, R.E., Nguyen, H., Emerson, S.U., Purcell, R.H., Tillmann, H.L., et al. (2011) Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury. Gastroenterology, 141, 1665-1672.e9.
http://dx.doi.org/10.1053/j.gastro.2011.07.051

[19]   Kaplowitz, N. (2004) Drug-Induced Liver Injury. Clinical Infectious Diseases, 38, S44-S48.
http://dx.doi.org/10.1086/381446

[20]   Elinav, E., Pinsker, G., Safadi, R., Pappo, O., Bromberg, M., Anis, E., Keinan-Boker, L., Broide, E., Ackerman, Z., Kaluski, D.N. and Lev, B. (2007) Association between Consumption of Herbalife? Nutritional Supplements and Acute Hepatotoxicity. Journal of Hepatology, 47, 514-520.
http://dx.doi.org/10.1016/j.jhep.2007.06.016

[21]   Johannsson, M., Ormarsdottir, S. and Olafsson, S. (2010) Hepatotoxicity Associated with the Use of Herbalife. Laeknabladid, 96, 167-172.

[22]   Manso, G., López-Rivas, L., Salgueiro, M.E., Duque, J.M., Jimeno, F.J., Andrade, R.J. and Lucena, M.I. (2011) Continuous Reporting of New Cases in Spain Supports the Relationship between Herbalife? Products and Liver Injury. Pharmacoepidemiology and Drug Safety, 20, 1080-1087.
http://dx.doi.org/10.1002/pds.2180

[23]   Schoepfer, A.M., Engel, A., Fattinger, K., Marbet, U.A., Criblez, D., Reichen, J., Zimmermann, A. and Oneta, C.M. (2007) Herbal Does Not Mean Innocuous: Ten Cases of Severe Hepatotoxicity Associated with Dietary Supplements from Herbalife? Products. Journal of Hepatology, 47, 521-526.
http://dx.doi.org/10.1016/j.jhep.2007.06.014

 
 
Top